TERT-BUTYL (S)-2-(4-FLUORO-3,5-DIMETHYLPHENYL)-4-METHYL-3-(2-OXO-2,3-DIHYDRO-1H-IMIDAZOL-1-YL)-2,4,6,7-TETRAHYDRO-5H-PYRAZOLO(4,3-C)PYRIDINE-5-CARBOXYLATE
UNII TW7T4UJ9KZ
Substance Identification & Data
This profile provides standardized clinical and technical data for Tert-butyl (s)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1h-imidazol-1-yl)-2,4,6,7-tetrahydro-5h-pyrazolo(4,3-c)pyridine-5-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) TW7T4UJ9KZ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2212021-61-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H28FN5O3 QQFGLFJMCFLDIO-HNNXBMFYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Tert-butyl (s)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-2,3-dihydro-1h-imidazol-1-yl)-2,4,6,7-tetrahydro-5h-pyrazolo(4,3-c)pyridine-5-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.